SSA
CTSO icon

Schonfeld Strategic Advisors’s Cytosorbents Corp CTSO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22,935
Closed -$50K – 2992
2022
Q2 		$50K Buy
22,935
+9,235
+67% +$21.2K ﹤0.01% 2224
2022
Q1 		$43K Buy
+13,700
New +$49.1K ﹤0.01% 2354

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Schonfeld Strategic Advisors's CTSO Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 22,935 shares — an estimated $50K sold.

Schonfeld Strategic Advisors first reported a position in CTSO in Q1 2022 and held it in 2 quarters. The position peaked at $50K in Q2 2022. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 22,935 Cytosorbents Corp shares in Q3 2022, an estimated $50K.
  • Schonfeld Strategic Advisors first reported a position in Cytosorbents Corp in Q1 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Cytosorbents Corp position peaked at $50K in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.